Starting January 2, 2020, prescriptions for certain codeine containing liquid preparations will require a Controlled Prescription Program duplicate prescription form. As with all Controlled Prescription Program drugs, these preparations must also be stored in a time-delay safe.
The College is set to begin developing standards and criteria, as well as bylaw and policy changes in order to implement mandatory anonymous Medication Incident Reporting in all pharmacies by 2022/2023.
September 30th has been declared Orange Shirt Day, in recognition of the harm the residential school system has left on generations of indigenous families and their communities. Wear an orange shirt and help create awareness of the individual, family and inter-generational impacts of Residential Schools in Canada.
New reporting requirements for Medical Assistance in Dying (MAID) have been in in effect since November 1, 2018. As part of the new reporting process, all provincial and federal reportable information began to be collected through new provincial forms for MAiD through a streamlined the reporting process which fulfilled both the provincial and federal reporting obligations for MAiD.
Zuclopenthixoldecanoate is a first generation depot antipsychotic available in Canada in 200mg /ml solution for injection (ampoule). It is usually simply known by its brand name ClopixolR. It is used for maintenance treatment of schizophrenia or psychosis.
There has been a vast increase in the number and quality of forged prescriptions for narcotic-containing substances in pharmacy practice. Given the current opioid crisis, it is imperative that registrants ensure these medications are dispensed appropriately and as intended by a patient’s prescriber.
June is National Indigenous History Month and the College would like to remind all Canadians to take a moment to reflect on, recognize and celebrate the unique heritage, diverse cultures and outstanding contributions to Canadian society of First Nations, Inuit and Metis peoples.